References
- Parchi P, Capellari S, Chin S et al. A subtype of sporadic prion disease mimicking fatal familial insomnia. Neurology52, 1757–1763 (1999).
- Montagna P, Gambetti P, Cortelli P, Lugaresi E. Familial and sporadic fatal insomnia. Lancet Neurol.2, 167–176 (2003).
- Collinge J. Prion diseases of humans and animals: their causes and molecular basis. Ann. Rev. Neurosci.24, 519–50 (2001).
- Benestad SL, Sarradin P, Thu B et al. Cases of scrapie with unusual features in Norway and designation of a new type, Nor98. Vet. Rec.153, 202–220 (2003).
- Moum T, Olsaker I, Hopp P et al. Polymorphisms at codons 141 and 154 in the ovine prion protein gene are associated with scrapie Nor98 cases. J. Gen. Virol.86, 231–23 (2005).
- Le Dur A, Béringue V, Andréoletti O et al. A newly identified type of scrapie agent can naturally infect sheep with resistand PrP genotypes. Proc. Natl Acad. Sci. USA102, 16031–16036 (2005).
- Everest SJ, Thorne L, Barnicle DA et al. Atypical prion protein in sheep brain collected during the British scrapie-surveillance programme. J. Gen. Virol.87, 471–477 (2006).
- Casalone C, Zanusso G, Acutis P et al. Identification of a second bovine amyloidotic spongiform encephalopathy: molecular similarities with sporadic Crueutzfeldt–Jakob disease. Proc. Natl Acad. Sci. USA101, 3065–3070 (2004).
- Watts JC, Balachandran A, Westaway D. The expanding universe of prion diseases. PLoS Pathog.2, 0152–0163 (2006).
- Roels S, Renard C, De Bosschere H et al. Detection of polymorphisms in the prion protein gene in the Belgian sheep population: some prelimjinary data. Vet. Quart.26, 3–11 (2004).
- Johnson RT, Gibbs CJ Jr. Creutzfeldt–Jakob disease and related transmissible spongiform encephalopathies. N. Engl. J. Med.339, 1994–2004 (1998).
- Hilton DA. Pathogenesis and prevalence of variant Creutzfeldt–Jakob disease. J. Pathol.208, 134–141 (2006).
- Will RG, Ironside JW, Zeidler M et al. A new variant of Creutzfeldt–Jakob disease in the UK. Lancet347, 921–925 (1996).
- Bruce ME. ‘New variant’ Creutzfeldt–Jakob disease and bovine spongiform encephalopathy. Nat. Med.6, 258–259 (2000).
- Belay ED, Schonberger LB. Variant Creutzfeldt–Jakob disease and bovine spongiform encephalopathy. Clin. Lab. Med.22, 849–862 (2002).
- Balter M. Infectious diseases. Uncertainties plague projections of vCJD toll. Science294, 770–771 (2001).
- Ghani AC, Donnelly CA, Ferguson NM, Anderson RM. Updated projections of future vCJD deaths in the UK. BMC Infect. Dis.3, 4 (2003).
- Wadsworth JD, Joiner S, Hill AF et al. Tissue distribution of protease resistant prion protein in variant Creutzfeldt–Jakob disease using a highly sensitive immunoblotting assay. Lancet358, 171–180 (2001).
- Llewelyn CA, Hewitt PE, Knight RS et al. Possible transmission of variant Creutzfeldt–Jakob disease by blood transfusion. Lancet363, 417–421 (2004).
- Peden AH, Head MW, Ritchie DL et al. Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet364, 527–529 (2004).
- Porter SR. Prion disease: possible implications for oral health. J. Amer. Dent. Assn.134, 1486–1491 (2003).
- Will R. Acquired prion disease: iatrogenic CJD, variant CJD, kuru. Br. Med. Bull.66, 255–265 (2003).
- Ironside JW, Head MW. Variant Creutzfeldt–Jakob disease: risk of transmission by blood and blood products. Haemophilia10, 64–69 (2006).
- Head MW, Ironside JW. Mad cows and monkey business: the end of CJD? Lancet365, 730–731 (2005).
- Ironside JW, Bishop MT, Connolly K et al. Variant Creutzfeldt–Jakob disease: prion protein genotype analysis of positive appendix tissue samples from a retrospective prevalence study. Br. Med. J.332, 1186–1188 (2006).
- Brown P, Bradley R. 1755 and all that: a historical primer of transmissible spongiform encephalopathy. Br. Med. J.317, 1688–1692 (1998).
- Will R. Variant Creutzfeldt–Jakob disease. Folia Neuropathol.42, 77–83 (2004).
- Donnelly CA, Ferguson NM, Ghani AC, Anderson RM. Implications of BSE infection screening data for the scale of the British BSE epidemic and current European infection levels. Proc. R. Soc. Lond. B Biol. Sci.269, 2179–2190 (2002).
- Schreuder BE, Somerville RA. Bovine spongiform encephalopathy in sheep? Rev. Sci. Tech.22, 103–120 (2003).
- Baylis M, Houston F, Kao RR et al. BSE – a wolf in sheep’s clothing? Trends Microbiol.10, 563–570 (2002).
- Houston F, Goldmann W, Chong A et al. Prion diseases: BSE in sheep bred for resistance to infection. Nature423, 498 (2003).
- Belay ED, Maddox RA, Williams ES et al. Chronic wasting disease and potential transmission to humans. Emerg. Infect. Dis.10, 977–984 (2004).
- Angers RC, Browning SR, Seward TS et al. Prions in skeletal muscle of deer with chronic wasting disease. Science311, 1117 (2006).
- Cho HJ. Is the scrapie agent a virus? Nature262, 411–412 (1976).
- Riesner D, Kellings K, Wiese U et al. Prions and nucleic acids: search for “residual” nucleic acids and screening for mutations in the PrP-gene. Dev. Biol. Stand.80, 173–181 (1993).
- Bolton DC, McKinley MP, Prusiner SB. Identification of a protein that purifies with the scrapie prion. Science218, 1309–1311 (1982).
- Prusiner SB. Novel proteinaceous infectious particles cause scrapie. Science216, 136–144 (1982).
- Prusiner SB. Prions. Proc. Natl Acad. Sci. USA95, 13363–13383 (1998).
- Griffith JS. Self-replication and scrapie. Nature215, 1043–1044 (1967).
- Prusiner SB. Molecular biology of prion diseases. Science252, 1515–1522 (1991).
- Come JH, Fraser PE, Lansbury PT Jr. A kinetic model for amyloid formation in the prion diseases: importance of seeding. Proc. Natl Acad. Sci. USA90, 5959–5963 (1993).
- Pan KM, Baldwin M, Nguyen J et al. Conversion of α-helices into β-sheets features in the formation of the scrapie prion proteins. Proc. Natl Acad. Sci. USA90, 10962–10966 (1993).
- Kocisko DA, Come JH, Priola SA et al. Cell-free formation of protease-resistant prion protein. Nature370, 471–474 (1994).
- Saborio GP, Permanne B, Soto C. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature411, 810–813 (2001).
- Hill AF, Antoniou M, Collinge J. Protease-resistant prion protein produced in vitro lacks detectable infectivity. J. Gen. Virol.80, 11–14 (1999).
- Castilla J, Saa P, Hetz C, Soto C. In vitro generation of infectious scrapie prions. Cell121, 195–206 (2005).
- Bieschke J, Weber P, Sarafoff N et al. Autocatalytic self-propagation of misfolded prion protein. Proc. Natl Acad. Sci. USA101, 12207–12211 (2004).
- Bueler H, Aguzzi A, Sailer A et al. Mice devoid of PrP are resistant to scrapie. Cell73, 1339–1347 (1993).
- Weissmann C, Aguzzi A. Approaches to therapy of prion diseases. Annu. Rev. Med.56, 321–344 (2005).
- Mallucci G, Collinge J. Rational targeting for prion therapeutics. Nat. Rev. Neurosci.6, 23–34 (2005).
- Cashman NR, Caughey B. Prion diseases – close to effective therapy? Nat. Rev. Drug Discov.3, 874–884 (2004).
- Legname G, Baskakov IV, Nguyen HO et al. Synthetic mammalian prions. Science305, 673–676 (2004).
- Tschampa HJ, Herms JW, Schulz-Schaeffer WJ et al. Clinical findings in sporadic Creutzfeldt–Jakob disease correlate with thalamic pathology. Brain125, 2558–2566 (2002).
- Steinhoff BJ, Zerr I, Glatting M et al. Diagnostic value of periodic complexes in Creutzfeldt–Jakob disease. Ann. Neurol.56, 702–708 (2004).
- Zerr I, Poser S. Clinical diagnosis and differential diagnosis of CJD and vCJD. With special emphasis on laboratory tests. APMIS110, 88–98 (2002).
- Ingrosso L, Vetrugno V, Cardone F, Pocchiari M. Molecular diagnostics of transmissible spongiform encephalopathies. Trends Mol. Med.8, 273–280 (2002).
- Kordek R. The diagnosis of human prion diseases. Folia Neuropathol.38, 151–160 (2000).
- Prusiner SB, Cochran SP, Groth DF et al. Measurement of the scrapie agent using an incubation time interval assay. Ann. Neurol.11, 353–358 (1982).
- Bruce M, Chree A, McConnell I et al. Transmission of bovine spongiform encephalopathy and scrapie to mice: strain variation and the species barrier. Philos. Trans. R. Soc. Lond. B Biol. Sci.343, 405–411 (1994).
- Fraser H, Bruce ME, Chree A et al. Transmission of bovine spongiform encephalopathy and scrapie to mice. J. Gen. Virol.73, 1891–1897 (1992).
- Castilla J, Gutierrez AA, Brun A. Early detection of PrPres in BSE-infected bovine PrP transgenic mice. Arch. Virol.148, 677–691 (2006).
- Korth C, Kaneko K, Groth D et al. Abbreviated incubation times for human prions in mice expressing a chimeric mouse–human prion protein transgene. Proc. Natl Acad. Sci. USA100, 4784–4789 (2003).
- Safar JG, Scott M, Monaghan J et al. Measuring prions causing bovine spongiform encephalopathy or chronic wasting disease by immunoassays and transgenic mice. Nat. Biotechnol.20, 1147–1150 (2002).
- Baron T. Mouse models of prion disease transmission. Trends Mol. Med.8, 495–500 (2002).
- Buschmann A, Pfaff E, Reifenberg K et al. Detection of cattle-derived BSE prions using transgenic mice overexpressing bovine PrPC. Arch. Virol. Suppl,75–86 (2000).
- Butler D. Brussels seeks BSE diagnostic test to screen European cattle. Nature395, 205–206 (1998).
- EU Community Reference Laboratory for TSE. Comparative testing of three BSE tests: Enfer, BioRad TeSeE, and Prionics Check Western. Veterinary Laboratories Agency, Surrey, UK (2004).
- Schaller O, Fatzer R, Stack M et al. Validation of a western immunoblotting procedure for bovine PrPSc detection and its use as a rapid surveillance method for the diagnosis of bovine spongiform encephalopathy (BSE). Acta Neuropathol. (Berl.)98, 437–443 (1999).
- Oesch B, Doherr M, Heim D et al. Application of Prionics western blotting procedure to screen for BSE in cattle regularly slaughtered at Swiss abattoirs. Arch. Virol. Suppl.189–195 (2000).
- Biffiger K, Zwald D, Kaufmann L et al. Validation of a luminescence immunoassay for the detection of PrPSc in brain homogenate. J. Virol. Methods101, 79–84 (2002).
- Grassi J, Comoy E, Simon S et al. Rapid test for the preclinical postmortem diagnosis of BSE in central nervous system tissue. Vet. Rec.149, 577–582 (2001).
- Yamakawa Y, Hagiwara K, Nohtomi K et al. Atypical proteinase K-resistant prion protein PrPres observed in an apparently healthy 23-month-old Holstein steer. J. Virol. Methods Jpn J. Infect. Dis.56, 221–222 (2003).
- Safar J, Wille H, Itri V et al. Eight prion strains have PrPSc molecules with different conformations. Nat. Med.4, 1157–1165 (1998).
- Tatzelt J, Groth DF, Torchia M et al. Kinetics of prion protein accumulation in the CNS of mice with experimental scrapie. Neuropathol. Exp. Neurol. J.58, 1244–1249 (1999).
- Yakovleva O, Janiak A, McKenzie C et al. Effect of protease treatment on plasma infectivity in variant Creutzfeldt–Jakob disease mice. Transfusion44, 1700–1705 (2004).
- Mhawech P. 14-3-3 proteins – an update. Cell Res.15, 228–236 (2006).
- Van Everbroeck B, Boons J, Cras P. Cerebrospinal fluid biomarkers in Creutzfeldt–Jakob disease. Clin. Neurol. Neurosurg.107, 355–360 (2005).
- Sánchez-Valle R, Saiz A, Graus F. 14-3-3 protein isoforms and atypical patters of the 14-3-3 assay in the diagnosis of Creutzfeldt–Jakob disease. Neurosci. Lett.320, 69–72 (2002).
- Zerr I, Pochiari M, Collins S et al. Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt–Jakob disease. Neurology55, 811–815 (2000).
- Aguzzi A. Prions and the immune system: a journey through gut, spleen, and nerves. Adv. Immunol.81, 123–171 (2003).
- Kimberlin RH, Walker CA. Pathogenesis of scrapie in mice after intragastric infection. Virus Res.12, 213–220 (1989).
- Mishra RS, Basu S, Gu Y et al. Protease-resistant human prion protein and ferritin are cotransported across Caco-2 epithelial cells: implications for species barrier in prion uptake from the intestine. J. Neurosci.24, 11280–11290 (2004).
- Hilton DA, Ghani AC, Conyers L et al. Accumulation of prion protein in tonsil and appendix: review of tissue samples. Br. Med. J.325, 633–634 (2002).
- Hilton DA, Fathers E, Edwards P et al. Prion immunoreactivity in appendix before clinical onset of variant Creutzfeldt–Jakob disease. Lancet352, 703–704 (1998).
- Hill AF, Zeidler M, Ironside J, Collinge J. Diagnosis of new variant Creutzfeldt–Jakob disease by tonsil biopsy. Lancet349, 99–100 (1997).
- Hilton DA, Conyers L, Conyers L et al. Prevalence of lymphoreticular prion protein accumulation in UK tissue samples. J. Pathol.203, 733–739 (2004).
- Bosque PJ, Ryou C, Telling G et al. Prions in skeletal muscle. Proc. Natl Acad. Sci. USA99, 3812–3817 (2002).
- Andreoletti O, Simon S, Lacroux C et al. PrPSc accumulation in myocytes from sheep incubating natural scrapie. Nat. Med.10, 591–293 (2004).
- Thomzig A, Schulz-Schaeffer W, Kratzel C et al. Preclinical deposition of pathological prion protein PrPSc in muscles of hamsters orally exposed to scrapie. J. Clin. Invest.113, 1465–1472 (2004).
- Buschmann A, Groschup MH. Highly bovine spongiform encephalopathy-sensitive transgenic mice confirm the essential restriction of infectivity to the nervous system in clinically diseased cattle. J. Infect. Dis.192, 934–942 (2005).
- Glatzel M, Abela E, Maissen M, Aguzzi A. Extraneural pathologic prion protein in sporadic Creutzfeldt–Jakob disease. N. Engl. J. Med.349, 1812–1820 (2003).
- Shaked GM, Shaked Y, Kariv-Inbal Z et al. A protease-resistant prion protein isoform is present in urine of animals and humans affected with prion diseases. J. Biol. Chem.276, 31479–31482 (2001).
- Furukawa H, Doh-ura K, Okuwaki R et al. A pitfall in diagnosis of human prion diseases using detection of protease-resistant prion protein in urine. Contamination with bacterial outer membrane proteins. J. Biol. Chem.279, 23661–23667 (2004).
- Serban A, Legname G, Hansen K et al. Immunoglobulins in urine of hamsters with scrapie. J. Biol. Chem.279, 48817–48820 (2004).
- Seeger H, Heikenwalder M, Zeller N et al. Coincident scrapie infection and nephritis lead to urinary prion excretion. Science310, 324–326 (2005).
- Ligios C, Sigurdson CJ, Santucciu C et al. PrPSc in mammary glands of sheep affected by scrapie and mastitis. Nat. Med.11, 1137–1138 (2005).
- Hunter N, Foster J, Chong A et al. Transmission of prion diseases by blood transfusion. J. Gen. Virol.83, 2897–2905 (2002).
- Houston F, Foster JD, Hunter N, Bostock CJ. Transmission of BSE by blood transfusion in sheep. Lancet356, 999–1000 (2000).
- Cervenakova L, Yakovleva O, McKenzie C et al. Similar levels of infectivity in the blood of mice infected with human-derived vCJD and GSS strains of transmissible spongiform encephalopathy. Transfusion43, 1687–1694 (2003).
- Brown P, Cervenakova L, McShane LM et al. Further studies of blood infectivity in an experimental model of transmissible spongiform encephalopathy, with an explanation of why blood components do not transmit Creutzfeldt–Jakob disease in humans. Transfusion39, 1169–1178 (1999).
- Brown P, Rohwer RG, Dunstan BC et al. The distribution of infectivity in blood components and plasma derivatives in experimental models of transmissible spongiform encephalopathy. Transfusion38, 810–816 (1998).
- Bons N, Lehmann S, Mestre-Frances N et al. Brain and buffy coat transmission of bovine spongiform encephalopathy to the primate Microcebus murinus. Transfusion42, 513–516 (2002).
- Soto C. Diagnosing prion diseases: needs, challenges and hopes. Nat. Rev. Microbiol.2, 809–819 (2004).
- Groschup MH, Harmeyer S, Pfaff E. Antigenic features of prion proteins of sheep and of other mammalian species. J. Immunol. Methods207, 89–101 (1997).
- Demart S, Fournier JG, Creminon C et al. New insight into abnormal prion protein using monoclonal antibodies. Biochem. Biophys. Res. Commun.265, 652–657 (1999).
- Kascsak RJ, Fersko R, Pulgiano D et al. Immunodiagnosis of prion disease. Immunol. Invest.26, 259–268 (1997).
- Korth C, Sterli B, Streit P et al. Prion (PrPSc)-specific epitope defined by a monoclonal antibody. Nature390, 74–77 (1997).
- Korth C, Streit P, Oesch B. Monoclonal antibodies specific for the native, disease-associated isoform of the prion protein. Methods Enzymol.309, 106–122 (1999).
- Paramithiotis E, Pinard M, Lawton T et al. A prion protein epitope selective for the pathologically misfolded conformation. Nat. Med.9, 893–899 (2003).
- Curin Serbec V, Bresjanac M, Popovic M et al. Monoclonal antibody against a peptide of human prion protein discriminates between Creutzfeldt–Jacob’s disease-affected and normal brain tissue. J. Biol. Chem.279, 3694–3698 (2004).
- Zou WQ, Zheng J, Gray DM et al. Antibody to DNA detects scrapie but not normal prion protein. Proc. Natl Acad. Sci. USA101, 1380–1385 (2004).
- Lane A, Stanley CJ, Dealler S, Wilson SM. Polymeric ligands with specificity for aggregated prion proteins. Clin. Chem.49, 1774–1775 (2003).
- Fischer MB, Roeckl C, Parizek P et al. Binding of disease-associated prion protein to plasminogen. Nature408, 479–483 (2000).
- Maissen M, Roeckl C, Glatzel M et al. Plasminogen binds to disease-associated prion protein of multiple species. Lancet357, 2026–2028 (2001).
- Kornblatt JA, Marchal S, Rezaei H et al. The fate of the prion protein in the prion/plasminogen complex. Biochem. Biophys. Res. Commun.305, 518–522 (2003).
- Shaked Y, Engelstein R, Gabizon R. The binding of prion proteins to serum components is affected by detergent extraction conditions. J. Neurochem.82, 1–5 (2002).
- Praus M, Kettelgerdes G, Baier M et al. Stimulation of plasminogen activation by recombinant cellular prion protein is conserved in the NH2-terminal fragment PrP23–110. Thromb. Haemost.89, 812–819 (2003).
- Rhie A, Kirby L, Sayer N et al. Characterization of 2´-fluoro-RNA aptamers that bind preferentially to disease-associated conformations of prion protein and inhibit conversion. J. Biol. Chem.278, 39697–39705 (2003).
- Proske D, Gilch S, Wopfner F et al. Prion-protein-specific aptamer reduces PrPSc formation. Chembiochem3, 717–725 (2002).
- Saunders C, Herbert P, Rowe G et al.In-vitro evaluation of the PALL Leukotrap Affinity Prion Reduction Filter as a secondary device following primary leucoreduction. Vox Sang89, 220–228 (2005).
- Bellon A, Seyfert-Brandt W, Lang W et al. Improved conformation-dependent immunoassay: suitability for human prion detection with enhanced sensitivity. J. Gen. Virol.84, 1921–1925 (2003).
- Lee IS, Long JR, Prusiner SB, Safar JG. Selective precipitation of prions by polyoxometalate complexes. J. Am. Chem. Soc.127, 13802–13803 (2005).
- Polymenidou M, Verghese-Nikolakaki S, Groschup M et al. A short purification process for quantitative isolation of PrPSc from naturally occurring and experimental transmissible spongiform encephalopathies. BMC Infect. Dis.2, 23 (2002).
- Soto C, Saborio GP, Anderes L. Cyclic amplification of protein misfolding: application to prion-related disorders and beyond. Trends Neurosci.25, 390–394 (2002).
- Castilla J, Saa P, Soto C. Detection of prions in blood. Nat. Med.11, 982–985 (2005).
- Soto C, Anderes L, Suardi S et al. Pre-symptomatic detection of prions by cyclic amplification of protein misfolding. FEBS Lett.579, 638–642 (2005).
- Klohn PC, Stoltze L, Flechsig E et al. A quantitative, highly sensitive cell-based infectivity assay for mouse scrapie prions. Proc. Natl Acad. Sci. USA100, 11666–11671 (2003).
- Yang WC, Schmerr MJ, Jackman R et al. Capillary electrophoresis-based noncompetitive immunoassay for the prion protein using fluorescein-labeled protein a as a fluorescent probe. Anal. Chem.77, 4489–4494 (2005).
- Schmerr MJ, Jenny AL, Bulgin MS et al. Use of capillary electrophoresis and fluorescent labeled peptides to detect the abnormal prion protein in the blood of animals that are infected with a transmissible spongiform encephalopathy. J. Chromatogr. A853, 207–214 (1999).
- Cervenakova L, Brown P, Soukharev S et al. Failure of immunocompetitive capillary electrophoresis assay to detect disease-specific prion protein in buffy coat from humans and chimpanzees with Creutzfeldt–Jakob disease. Electrophoresis24, 853–859 (2003).
- Bieschke J, Giese A, Schulz-Schaeffer W et al. Ultrasensitive detection of pathological prion protein aggregates by dual-color scanning for intensely fluorescent targets. Proc. Natl Acad. Sci. USA97, 5468–5473 (2000).
- Rubenstein R, Gray PC, Wehlburg CM et al. Detection and discrimination of PrPSc by multi-spectral ultraviolet fluorescence. Biochem. Biophys. Res. Commun.246, 100–106 (1998).
- Lasch P, Schmitt J, Beekes M et al. Antemortem identification of bovine spongiform encephalopathy from serum using infrared spectroscopy. Anal. Chem.75, 6673–6678 (2003).
- Kneipp J, Beekes M, Lasch P, Naumann D. Molecular changes of preclinical scrapie can be detected by infrared spectroscopy. J. Neurosci.22, 2989–2997 (2002).
- Carmona P, Monleón E, Monzón M et al.In vivo detection of scrpie cases from blood by infrared spectroscopy. J. Gen. Virol.86, 3425–3431 (2005).
- Carmona P, Monleón E, Monzón M et al. Raman analysis of prion protein in blood cell membranes from naturally affected scrapie sheep. Chem. Biol.11, 759–764 (2004).
- Trieschmann L, Santos A, Kaschig K et al. Ultra-sensitive detection of prion protein fibrils by flow cytometry in blood from cattle affected with bovine spongiform encephalopathy. BMC Biotechnol.5, 26 (2005).
- Gofflot S, El MB, Zorzi D et al. Immuno-quantitative polymerase chain reaction for detection and quantitation of prion protein. J. Immunoassay Immunochem.25, 241–258 (2004).
- Gofflot S, Deprez M, el Moualij B et al. Immunoquantitative PCR for prion protein detection in sporadic Creutzfeldt–Jakob disease. Clin. Chem.51, 1605–1611 (2005).
- Barletta JM, Edelman DC, Highsmith WE, Constatine NT. Detection of ultra-low levels of pathologic prion protein in scrapie infected hamster brain homogenates using real-time immuno-PCR. J. Virol. Methods127, 154–164 (2005).
- Grosset A, Moskowitz K, Nelsen C et al. Rapid presymptomatic detection of PrPSc via conformationally responsive palindromic PrP peptides. Peptides26, 2193–2200 (2005).
- Caughey B. Probing for prions: recognizing misfolded PrP. Nat. Med.9, 819–820 (2003).
Websites
- State of Colorado. CWD Info and testing (2006) http://wildlife.state.co.us/hunting/biggame/cwd
- Centers for Disease Control and Prevention. Prion Diseases (2006) www.cdc.gov/ncidod/dvrd/prions
- National Creutzfeldt–Jakob Disease Surveillance Unit. CJD Statistics to March 31, 2006 www.cjd.ed.ac.uk
- Andrews NJ. Incidence of variant Creutzfeldt–Jakob disease onsets and deaths in the UK (2006) www.cjd.ac.uk/vejdgdec05.html
- Health Protection Agency. A new case of variant CJD associated with blood transfusion (2006) www.hpa.org.uk/hpa/news/articles/press_ releases/2006/060209_cjd.htm
- Department for Environment Food and Rural Affairs. BSE Statistics: confirmed cases of BSE reported worldwide (2006) www.defra.gov.uk/animalh/bse/statistics/ weeklystats.html#act
- Department for Environment Food and Rural Affairs. BSE: disease control and eradication (2006) www.defra.gov.uk/animalh/bse/controls-eradication/index.html
- Prionics www.prionics.ch
- Abbott Diagnostics: Reagents and Tests www.abbottdiagnostics.com/reagents_tests
- Bio-Rad test used in 25 countries to detect BSE and other TSEs www.biorad.com/pages/CRP/bsetest.html
- European Food Safety Authority www.efsa.eu.int
- NeuroPrion and the German TSE Research Platform. Prion 2005: between fundamentals and society’s needs (2006) www.prion2005.com
- Cambridge Healthtech Institute. Transmissible spongiform encephalopathies, 10th Annual Meeting: the definitive American TSE meeting (2006) www.healthtech.com/2006/tse/index.asp